safety of semaglutide for weight loss New Side Effects (Ozempic & Wegovy): Symptoms, Risks and Semaglutide: Double-edged Sword with Risks

In a large clinical trial, semaglutide reduced the risk of major cardiovascular events such as heart attack, stroke, or cardiovascular death by about 20% in people with overweight or obesity and existing heart disease

This means the current duopoly between Eli Lilly and Novo Nordisk could start to be diluted, potentially leading to more competition in the market

A large study found supplementing with folic acid, B6, and B12 significantly reduced the risk of AMD in adults with cardiovascular risk factors

The use of Ozempic (semaglutide) may increase the risk of developing thyroid cancer

FOR MAINS What are the side effects of GLP-1 drugs